Drug Innovation
Blog
To Grow America’s Economy, We Need Tax Reform and Spending Reform
Washington D.C. has turned its sights on tax reform. Critics, almost reflexively, oppose the effort based on claims that tax reform will increase the deficit. A little perspective is in order, consequently. The chart below presents data on total federal, state, and local government revenues and spending relative to the ...
Business & Economics
Let Health Insurance Be Insurance
One of the many flaws with our current health care system is that, too often, health insurance coverage fails people precisely when they need it the most. It’s as if your car insurance has been paying the cost for your oil changes for years, but won’t pay the costs to ...
Business & Economics
Lewis Carroll and the Pricing of Pharmaceuticals
Imagine a pharmaceutical market designed by Lewis Carroll’s Mad Hatter. In contrast to almost every other market, he might begin by charging wholesale prices that are higher than retail prices. He would then make sure that the higher wholesale price goes, the lower retail prices can become. And finally, he ...
Commentary
Just Say No to Pay-fors
The Children’s Health Insurance Program (CHIP) was established in 1997—a program that gives states federal matching funds to provide health insurance to children from families that are too wealthy to qualify for Medicaid, but too poor to afford private insurance. However, current federal funding for CHIP expires on September 30th. ...
Business & Economics
Enriching Lawyers Is Not the Solution to the Opioid Crisis
Effective health care reforms must reduce the excessive costs imposed by frivolous lawsuits. Studies have shown that medical tort reform could reduce total health care premiums between 1 and 3 percent. As estimated by the American Action Forum, this could mean “roughly $15 billion” in savings from effective (but partial) ...
California
Reforms Should Improve the Efficiency of the Pharmaceutical Market
The refrain that pharmaceuticals are driving the health care affordability problem has been repeated so often that it is becoming an illusory truth – people believe it to be true simply because they have heard it repeated so often. Obviously, repeating the same incorrect statement over and over again does ...
Drug Innovation
ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name
Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
Commentary
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
Drug Innovation
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Drug Innovation
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
To Grow America’s Economy, We Need Tax Reform and Spending Reform
Washington D.C. has turned its sights on tax reform. Critics, almost reflexively, oppose the effort based on claims that tax reform will increase the deficit. A little perspective is in order, consequently. The chart below presents data on total federal, state, and local government revenues and spending relative to the ...
Let Health Insurance Be Insurance
One of the many flaws with our current health care system is that, too often, health insurance coverage fails people precisely when they need it the most. It’s as if your car insurance has been paying the cost for your oil changes for years, but won’t pay the costs to ...
Lewis Carroll and the Pricing of Pharmaceuticals
Imagine a pharmaceutical market designed by Lewis Carroll’s Mad Hatter. In contrast to almost every other market, he might begin by charging wholesale prices that are higher than retail prices. He would then make sure that the higher wholesale price goes, the lower retail prices can become. And finally, he ...
Just Say No to Pay-fors
The Children’s Health Insurance Program (CHIP) was established in 1997—a program that gives states federal matching funds to provide health insurance to children from families that are too wealthy to qualify for Medicaid, but too poor to afford private insurance. However, current federal funding for CHIP expires on September 30th. ...
Enriching Lawyers Is Not the Solution to the Opioid Crisis
Effective health care reforms must reduce the excessive costs imposed by frivolous lawsuits. Studies have shown that medical tort reform could reduce total health care premiums between 1 and 3 percent. As estimated by the American Action Forum, this could mean “roughly $15 billion” in savings from effective (but partial) ...
Reforms Should Improve the Efficiency of the Pharmaceutical Market
The refrain that pharmaceuticals are driving the health care affordability problem has been repeated so often that it is becoming an illusory truth – people believe it to be true simply because they have heard it repeated so often. Obviously, repeating the same incorrect statement over and over again does ...
ISSUE BRIEF: Nevada Proposal To Regulate Excess Costs Are Price Controls By Another Name
Click here to download a copy of PRI’s Issue Brief Senate Bill 265 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with drugs for diabetes, which are defined as the excess costs over the highest price in other developed countries. The Fiscal Notes on SB 265 ...
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
